Your browser doesn't support javascript.
loading
Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.
Gao, Tiantao; Hu, Quanfang; Hu, Xi; Lei, Qian; Feng, Zhanzhan; Yu, Xi; Peng, Cuiting; Song, Xuejiao; He, Hualong; Xu, Ying; Zuo, Weiqiong; Zeng, Jun; Liu, Zhihao; Yu, Luoting.
Afiliação
  • Gao T; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China.
  • Hu Q; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China.
  • Hu X; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China.
  • Lei Q; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China.
  • Feng Z; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China.
  • Yu X; Carey Business School, Johns Hopkins University, Baltimore, MD, 21202, USA.
  • Peng C; School of Chemical Engineering, Sichuan University, Chengdu, 610041, China.
  • Song X; Research Center for Public Health and Preventive Medicine, West China School of Public Health, Sichuan University, Chengdu, Sichuan, China.
  • He H; School of Chemical Engineering, Sichuan University, Chengdu, 610041, China.
  • Xu Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China.
  • Zuo W; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China.
  • Zeng J; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China.
  • Liu Z; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China. Electronic address: liuzhihao@scu.edu.cn.
  • Yu L; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Collaborative Innovation Center for Biotherapy, 17 #3rd Section, Ren Min South Road, Chengdu, 610041, China. Electronic address: yuluot@scu.edu.cn.
Cancer Lett ; 445: 11-23, 2019 03 31.
Article em En | MEDLINE | ID: mdl-30590102
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Quinases de Proteína Quinase Ativadas por Mitógeno / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Quinases de Proteína Quinase Ativadas por Mitógeno / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Idioma: En Ano de publicação: 2019 Tipo de documento: Article